Alpha cognition to report fourth quarter and full year 2024 financial results and operating overview

Vancouver, british columbia & dallas--(business wire)--alpha cognition inc. (nasdaq: acog), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will release financial results for the fourth quarter and full year ended december 31, 2024 on march 31, 2025 after close of market. following the release, management will host a conference call to review financial and operating results. conference call information: to participate in the.
ACOG Ratings Summary
ACOG Quant Ranking